Salubris (Chengdu) Biotech Co., Ltd.

Follow

Organization

Chengdu, CN

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Human neuregulin-1 (NRG-1) recombinant fusion protein compositions...
- Patent number 11,718,652
- Issue date Aug 8, 2023
- Salubris Biotherapeutics, Inc.
- John Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human neuregulin-1 (NRG-1) recombinant fusion protein compositions...
- Patent number 11,046,741
- Issue date Jun 29, 2021
- Salubris Biotherapeutics, Inc.
- John Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
HUMAN NEUREGULIN-1 (NRG-1) RECOMBINANT FUSION PROTEIN COMPOSITIONS...
- Publication number 20230322877
- Publication date Oct 12, 2023
- Salubris Biotherapeutics, Inc.
- John LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMAN NEUREGULIN-1 (NRG-1) RECOMBINANT FUSION PROTEIN COMPOSITIONS...
- Publication number 20210347841
- Publication date Nov 11, 2021
- Salubris Biotherapeutics, Inc.
- John LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES BINDING PD-1 AND USES THEREOF
- Publication number 20210095032
- Publication date Apr 1, 2021
- Salubris (Chengdu) Biotech Co., Ltd.
- John LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES OR ANTIGEN-BINDING PORTIONS BINDING CD40 AND USES THEREOF
- Publication number 20200332017
- Publication date Oct 22, 2020
- Salubris (Chengdu) Biotech Co., Ltd.
- John Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks